Literature DB >> 8473746

Regulation of expression of IL-1 receptor antagonist protein in human synovial and dermal fibroblasts.

R F Krzesicki1, C A Hatfield, M J Bienkowski, J C McGuire, G E Winterrowd, D L Chapman, A E Berger, R N McEwan, D B Carter, J G Chosay.   

Abstract

The IL-1R antagonist protein (IRAP) is a competitive inhibitor of IL-1, which is predominantly synthesized by monocytes. We show that this molecule is also expressed in human synovial fibroblasts and dermal fibroblasts (CRL 1445). IRAP mRNA was regulated in a time- and dose-dependent manner by IL-1 alpha, TNF-alpha, LPS, and PMA. Maximal induction of IRAP mRNA was observed between 8 and 16 h after stimulation with IL-1 alpha (1 U/ml), TNF-alpha (10 U/ml), LPS (50 ng/ml), and PMA (10 ng/ml). Their relative efficacy was as follows: PMA > LPS > IL-1 alpha > TNF-alpha. Potentiation was observed when fibroblasts were treated with IL-1 alpha plus basic fibroblast growth factor and IL-1 alpha plus platelet-derived growth factor-BB homodimer. Although LPS and PMA were the best inducers of IRAP mRNA, quantitation of the IRAP protein revealed that its synthesis and release were differentially regulated. Immunoprecipitation and SDS-PAGE of culture supernatant from LPS-treated cells and cell lysates of fibroblasts treated with LPS or PMA showed a single IRAP band with a molecular mass of approximately 22 kDa. Very little IRAP was detected in culture supernatants of cells treated with PMA. Quantitation of IRAP revealed that LPS induced the synthesis of secreted IRAP that was released, whereas the majority of the protein induced by PMA remained cell-associated. Reverse transcriptase-polymerase chain reaction amplification demonstrated that although LPS and PMA induced both transcripts, LPS preferentially induced secreted IRAP, whereas PMA differentially induced intracellular IRAP mRNA. Fibroblasts synthesize at least two different forms of IRAP depending on the inducing signal, and may regulate the inflammatory response by dampening the proinflammatory effects of IL-1 via a negative feedback mechanism with IRAP. The relative importance of fibroblast sIRAP vs intracellular IRAP in regulating the inflammatory response by the connective tissue remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8473746

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention.

Authors:  Z Szekanecz; A E Koch; S L Kunkel; R M Strieter
Journal:  Drugs Aging       Date:  1998-05       Impact factor: 3.923

2.  Low endogenous prostaglandin E2 predisposes to relapsing inflammation in experimental rat enterocolitis.

Authors:  H M Kandil; R A Argenzio; R B Sartor
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

Review 3.  Regulation of serum amyloid A protein expression during the acute-phase response.

Authors:  L E Jensen; A S Whitehead
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

4.  Serum levels of interleukin-1 receptor antagonist (IL-1ra) in thyroid cancer patients.

Authors:  Sebastian Niedźwiecki; Tomasz Stepień; Krzysztof Kuzdak; Henryk Stepień; Roman Krupiński; Daniel Seehofer; Nada Rayes; Frank Ulrich
Journal:  Langenbecks Arch Surg       Date:  2007-12-07       Impact factor: 3.445

5.  Novel production of interleukin-1 receptor antagonist peptides in normal human cornea.

Authors:  M C Kennedy; J T Rosenbaum; J Brown; S R Planck; X Huang; C A Armstrong; J C Ansel
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

6.  Quantitative proteomic analysis of LPS-induced differential immune response associated with TLR4 Polymorphisms by multiplex amino acid coded mass tagging.

Authors:  Sheng Gu; Tianyi Wang; Xian Chen
Journal:  Proteomics       Date:  2008-08       Impact factor: 3.984

7.  Attenuation of oxidant-induced lung injury by 21-aminosteroids (lazaroids): correlation with the mRNA expression for E-selectin, P-selectin, ICAM-1, and VCAM-1.

Authors:  R L Griffin; R F Krzesicki; S F Fidler; C L Rosenbloom; J A Auchampach; A M Manning; J V Haas; S K Cammarata; J E Chin; I M Richards
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

8.  Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist.

Authors:  M Muzio; N Polentarutti; M Sironi; G Poli; L De Gioia; M Introna; A Mantovani; F Colotta
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.